Cannabis Extract Market, by Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabigerol (CBG), Cannabinol), by Product Type (Oil, Shatter, Wax, Hash, Others (Gummies, Cream, etc.)), by Extract Type (Full Spectrum, Broad Spectrum, Isolat

Cannabis Extract Market, by Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabigerol (CBG), Cannabinol), by Product Type (Oil, Shatter, Wax, Hash, Others (Gummies, Cream, etc.)), by Extract Type (Full Spectrum, Broad Spectrum, Isolates), by Indication (Muscle Disorder (Dystonia), Neurological Disorder (Parkinson Disease), Pain Management, Recreational Use), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Cannabis is an herbal drug, it has chemicals like cannabinoids, including tetrahydrocannabinol (THC) and cannabidiol (CBD). Cannabis extract can be obtained from any part of the cannabis plant including stems, flowers, and leaves.

Cannabis extracts are available in various product types like oil, shatter, wax, hash and others (gummies, cream, etc.). Cannabis and cannabis derived products are used to treat a number of medical condition including, muscle disorder (Dystonia), neurological disorder (Parkinson Disease), pain management and recreational use.

Market Dynamics

The increasing awareness of medical use of cannabis globally, rising research and development activities, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive growth of the global cannabis extract market over the forecast period.

For instance, in May 2022, Jushi Holdings, Inc., a vertically integrated, multi state cannabis operator, launched the company’s first line of solventless live rosin extracts by its brand The Lab, initially it will exclusively carry The Lab Live Resin cartridges at beyond Hello retail locations in Pennsylvania.

Moreover, in 2021, Panaxia Labs Israel Ltd., a global pharma company, entered into a collaboration agreement with Neuraxpharm, Europe's Pharma Company focused on the treatment of Central Nervous System (CNS) disorders, and announced the expansion of their strategic collaboration into the Polish market, Under this agreement, the manufacture, commercialization, and distribution of Panaxia's advanced medical cannabis-based products will take place in Poland

Key features of the study:

• This report provides an in-depth analysis of the global cannabis extract market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cannabis extract market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Canopy Growth Corporation, Aurora Cannabis Inc., Tikun Olam, Cannabis Science Inc., Aphria Inc., Maricann Group Inc., Tilray Inc., VIVO Cannabis Inc., Medical Marijuana, Inc., STENOCARE, Cronos Group Inc., Terra Tech Corp., MedMen, Teva Pharmaceutical Industries Ltd., and Organigram Holdings Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global cannabis extract market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cannabis extract market

Detailed Segmentation:

• Global Cannabis Extract Market, By Active Ingredient:
• Tetrahydrocannabinol (THC)
• Cannabidiol (CBD)
• Cannabigerol (CBG)
• Cannabinol
• Global Cannabis Extract Market, By Product Type:
• Oil
• Shatter
• Wax
• Hash
• Others (Gummies, Cream, etc.)
• Global Cannabis Extract Market, By Extract Type:
• Full Spectrum
• Broad Spectrum
• Isolates
• Global Cannabis Extract Market, By Indication:
• Muscle Disorder (Dystonia)
• Neurological Disorder (Parkinson Disease)
• Pain Management
• Recreational Use
• Global Cannabis Extract Market, By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Global Cannabis Extract Market, By Region:
• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Country
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Canopy Growth Corporation.*
• Company Overview
• Material Portfolio
• Financial Performance
• Key Highlights
• Market Strategies
• Aurora Cannabis Inc.
• Tikun Olam
• Cannabis Science Inc.
• Aphria Inc.
• Maricann Group Inc.
• Tilray Inc.
• VIVO Cannabis Inc.
• Medical Marijuana, Inc.
• STENOCARE
• Cronos Group Inc.
• Terra Tech Corp.
• MedMen
• Teva Pharmaceutical Industries Ltd.
• Organigram Holdings Inc.

“*” marked represents similar segmentation in other categories in the respective section